http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-265331-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d037bc74e34c7d73dd883f208aef0518
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
filingDate 1961-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1961-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-265331-A1
titleOfInvention PROCEDURE FOR THE PREPARATION OF TRIMETOXY-BENZAMINES
abstract The invention comprises compounds of the formula <FORM:0897989/IV (b)/1> (wherein R and R1 are alkyl radicals each containing at most 8 carbon atoms) and their preparation by heating p-hydroxy-benzylamine with 3,4,5-trimethoxybenzoyl chloride in an inert anhydrous organic solvent in the presence of a tertiary amine, heating an alkali metal salt of the precipitated N-(p-hydroxybenzyl)-3,4,5-trimethoxybenzamide at 65 DEG C. to 70 DEG C. with an N-chloroethyl-3,3-dialkyl-azetidine in an inert anhydrous organic solvent, evaporating the mixture to dryness, taking up the residue in an organic solvent, evaporating after filtration of the inorganic salt, taking up the residue with diethyl ether and precipitating the product by adding light petroleum. An example is given. N - Chloroethyl - 3, 3 - dialkylazetidines are prepared by reacting 3,3-dialkylazetidines with ethylene oxide to give 3,3-dialkyl-1-(b -hydroxyethyl)-azetidines and reacting these with thionyl chloride. The compounds of the invention, which are stated to be antihistaminic and antiemetic agents, may be formulated as pharmaceutical compositions with solid or liquid carriers or diluents.
priorityDate 1960-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457572435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413177820
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415764904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13277192

Total number of triples: 25.